Intraperitoneal pretargeted radioimmunotherapy for colorectal peritoneal carcinomatosis

Completed Research Project
Sarah M. Cheal, Ph.D.
Last Updated: 
June 7, 2022

We developed theranostic intraperitoneal DOTA-ligand bound radionuclide-based pretargeted radioimmunotherapy (DOTA-PRIT) for treatment of peritoneal carcinomatosis. Mol. Cancer Ther.: 2022 Jan;21(1):125-137.

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065